| Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines … RA Sperling, PS Aisen, LA Beckett, DA Bennett, S Craft, AM Fagan, ... Alzheimer's & dementia 7 (3), 280-292, 2011 | 7173 | 2011 |
| Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium IG McKeith, DW Dickson, J Lowe, M Emre, JT O'brien, H Feldman, ... Neurology 65 (12), 1863-1872, 2005 | 5512 | 2005 |
| Membrane transporters in drug development Nature reviews Drug discovery 9 (3), 215-236, 2010 | 3221 | 2010 |
| Visualization of Aβ42 (43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42 (43) T Iwatsubo, A Odaka, N Suzuki, H Mizusawa, N Nukina, Y Ihara Neuron 13 (1), 45-53, 1994 | 2149 | 1994 |
| α-Synuclein is phosphorylated in synucleinopathy lesions H Fujiwara, M Hasegawa, N Dohmae, A Kawashima, E Masliah, ... Nature cell biology 4 (2), 160-164, 2002 | 2084 | 2002 |
| Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. M Baba, S Nakajo, PH Tu, T Tomita, K Nakaya, VM Lee, JQ Trojanowski, ... The American journal of pathology 152 (4), 879, 1998 | 1975 | 1998 |
| APP processing and synaptic function F Kamenetz, T Tomita, H Hsieh, G Seabrook, D Borchelt, T Iwatsubo, ... Neuron 37 (6), 925-937, 2003 | 1965 | 2003 |
| Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature PT Nelson, I Alafuzoff, EH Bigio, C Bouras, H Braak, NJ Cairns, ... Journal of Neuropathology & Experimental Neurology 71 (5), 362-381, 2012 | 1869 | 2012 |
| Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease RS Doody, RG Thomas, M Farlow, T Iwatsubo, B Vellas, S Joffe, ... New England Journal of Medicine 370 (4), 311-321, 2014 | 1585 | 2014 |
| AMPAR removal underlies Aβ-induced synaptic depression and dendritic spine loss H Hsieh, J Boehm, C Sato, T Iwatsubo, T Tomita, S Sisodia, R Malinow Neuron 52 (5), 831-843, 2006 | 1262 | 2006 |
| A phase 3 trial of semagacestat for treatment of Alzheimer's disease RS Doody, R Raman, M Farlow, T Iwatsubo, B Vellas, S Joffe, K Kieburtz, ... New England Journal of Medicine 369 (4), 341-350, 2013 | 1153 | 2013 |
| The role of presenilin cofactors in the γ-secretase complex N Takasugi, T Tomita, I Hayashi, M Tsuruoka, M Niimura, Y Takahashi, ... Nature 422 (6930), 438-441, 2003 | 1107 | 2003 |
| Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synuclein P Tu, JE Galvin, M Baba, B Giasson, T Tomita, S Leight, S Nakajo, ... Annals of neurology 44 (3), 415-422, 1998 | 702 | 1998 |
| Dominant and differential deposition of distinct β-amyloid peptide species, AβN3 (pE), in senile plaques TC Saido, T Iwatsubo, DMA Mann, H Shimada, Y Ihara, S Kawashima Neuron 14 (2), 457-466, 1995 | 702 | 1995 |
| Constitutive phosphorylation of the Parkinson's disease associated α-synuclein M Okochi, J Walter, A Koyama, S Nakajo, M Baba, T Iwatsubo, L Meijer, ... Journal of Biological Chemistry 275 (1), 390-397, 2000 | 666 | 2000 |
| DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers CF Lippa, JE Duda, M Grossman, HI Hurtig, D Aarsland, BF Boeve, ... Neurology 68 (11), 812-819, 2007 | 664 | 2007 |
| Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interaction in the liver K Ito, T Iwatsubo, S Kanamitsu, K Ueda, H Suzuki, Y Sugiyama Pharmacological reviews 50 (3), 387-412, 1998 | 637 | 1998 |
| Alzheimer's Aβ (1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells DG Cook, MS Forman, JC Sung, S Leight, DL Kolson, T Iwatsubo, ... Nature medicine 3 (9), 1021-1023, 1997 | 611 | 1997 |
| Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins S Taniguchi, N Suzuki, M Masuda, S Hisanaga, T Iwatsubo, M Goedert, ... Journal of Biological Chemistry 280 (9), 7614-7623, 2005 | 607 | 2005 |
| Lewy bodies contain altered α-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes CF Lippa, H Fujiwara, DMA Mann, B Giasson, M Baba, ML Schmidt, ... The American journal of pathology 153 (5), 1365-1370, 1998 | 568 | 1998 |
